Mega Lifesciences PCL (BKK:MEGA)
Thailand flag Thailand · Delayed Price · Currency is THB
35.00
0.00 (0.00%)
Sep 3, 2026, 4:36 PM ICT

Mega Lifesciences PCL Financials Overview

Millions THB. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
14,52614,19515,38515,71615,72714,172
Revenue Growth
1.50%-7.74%-2.10%-0.07%10.97%12.36%
Gross Profit
7,6377,4317,7967,1307,0805,947
Operating Income
3,0732,9503,4112,9392,7222,178
Net Income
2,1901,9122,0121,9932,2421,947
Earnings Per Share
2.512.192.312.292.572.23
EPS Growth
17.59%-4.99%0.99%-11.10%15.14%39.79%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Brands
9,2218,7358,3808,0128,0596,915
Original Equipment Manufacture (OEM)
377.82312.44306.21279.62314.11320.63
Distribution
4,9105,1266,6827,4137,3406,926
Unallocated Other Income
17.2621.2917.6910.8613.6510.99
Total
14,52614,19515,38515,71615,72714,172

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4,0084,6443,8582,7222,7992,540
Total Debt
694.75683.54491.24251.84420.87356.33
Net Cash (Debt)
3,3133,9603,3672,4702,3782,184
Net Cash Growth
8.00%17.63%36.31%3.86%8.89%273.44%
Net Cash Per Share
3.804.543.862.832.732.50

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
2,7592,7702,4011,9261,9972,727
Capital Expenditures
-547.63-663.89-247.53-274.65-304.6-151.4
Free Cash Flow
2,2122,1072,1541,6521,6922,575
Free Cash Flow Growth
94.48%-2.20%30.39%-2.38%-34.30%84.62%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
52.57%52.35%50.67%45.37%45.02%41.97%
Operating Margin
21.15%20.78%22.17%18.70%17.30%15.37%
Pretax Margin
19.32%16.94%15.29%14.39%16.50%16.07%
Profit Margin
15.08%13.47%13.08%12.68%14.25%13.74%
FCF Margin
15.22%14.84%14.00%10.51%10.76%18.17%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.6501.6001.6001.6001.6001.380
Dividend Per Share Growth
3.13%0%0%0%15.94%53.33%
Dividend Yield
4.68%5.00%5.31%4.56%4.08%3.38%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
13.9315.2814.4117.6118.1822.62
Forward PE
12.9913.0711.2914.5217.7622.85
P/FCF Ratio
13.8013.8713.4621.2524.0917.10
PS Ratio
2.102.061.882.232.593.11